WELL Health Technologies Corp. (TSX: WELL)’s Post

In case you missed our webinar on how to use the OMED Health Breath Analyzer for clinical research, watch it on demand now! 🔗https://ow.ly/86qR50TmVOR In this webinar, expert speakers cover key insights including understanding hydrogen and methane in gastrointestinal diseases, broader disease contexts, advanced OMED device technology, and expanding the On-Breath VOCs Atlas. Don't miss out on these insights! #BreathAnalysis #Breath

This month's 𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁 𝗢𝗻: lipid mediators! LC-MS has become a cornerstone technique in the research of lipid mediators, but it takes high sensitivity and specificity to help unravel the complex roles these molecules play in health and disease. Learn more about the importance and challenges of lipid mediators in our Spotlight on series 👉 https://bit.ly/3WgyKk3 #SpotlightOnSeries #Quantitation #LCMSAnalysis #SCIEX #LipidMediators

World Mitochondrial Disease Week: September 16–22 At Haeldi, we are committed to revolutionizing healthcare by making it accessible to all, and today, we highlight a critical yet often overlooked area of health – mitochondrial diseases. These rare disorders, affecting the powerhouse of our cells, impact every aspect of the human body and remain a challenge to diagnose and manage. With mitochondrial diseases affecting 1 in 5,000 people globally, it’s vital that we create more awareness, improve diagnosis, and develop better treatment pathways. Our vision at Haeldi is to create a unified digital health platform that ensures patients with such rare conditions have easy access to specialist care, telemedicine, home healthcare, and chronic disease management support. We believe that leveraging technologies under ABDM framework, Bhashini translation and AI-powered insights will not only help address the larger healthcare needs of the country but also provide hope for individuals living with rare conditions like mitochondrial diseases. Let’s stand together to #LightUpForMito and raise awareness for better diagnosis, research, and support for those living with mitochondrial diseases. How can we, as a community, support the mitochondrial disease community? Share your thoughts and let’s spark a meaningful conversation. #MitochondrialDisease #WorldMitoWeek #Haeldi #DigitalHealth #HealthcareInnovation #RareDiseases #ChronicDiseaseManagement #HealthForAll

How can #Parkinsons be treated in the future? Cecilia Lundberg investigates the potential use of viral #vectors that expresses vital neurotrophic factors as well as enzymes that produce neurotransmitters, ultimately supporting neuronal health amidst the disease. The challenge is to hit the target at the right time, place, and level. Read more about the latest breakthroughs using following link 👉 https://lnkd.in/di3w3VtS

Did you know that sepsis is the number one cause of death in hospitals, the number one cause for hospital readmissions, and the number one healthcare cost. However, new research and clinical trials offer hope for improving outcomes. In our latest science blog, we’ve summarised some cutting-edge developments in sepsis care, including innovative therapies, AI diagnostic tools, and promising trials.🤞 As we mark #WorldSepsisDay, it’s important to remember that early diagnosis and treatment are key. By staying informed and supporting advancements in sepsis care, we can help reduce the devastating impact of this condition, raise sepsis awareness, and help tackle this global health crisis. Read our latest blog to learn more👉 https://lnkd.in/esvVECKy #StopSepsis #SaveLives #SepsisPrevention

🔬 Dive into the convergence of clinical trials and real-world data within the realm of diabetic kidney disease research! 👩🔬 This study, conducted by experts, uncovers notable differences and promising synergies between these datasets. From demographic nuances to vital signs, witness how merging these sources enhances comprehension and treatment strategies. Read more: https://bit.ly/43xNCNj for more information on how we can help visit (www.bioviser.com) #diabetickidneydisease #researchinsights #clinicaltrials #realworlddata #healthtech #medicalresearch

Cancer markers are not as useful as you think - here's why. – 📬 Join 1000+ others for weekly health optimisation hacks here: https://buff.ly/3SkN1JF – 🌴Screen your health at our new oasis: Trapeze Rec Club. Book to reserve your slots: https://buff.ly/3w0FHLq – #healthspan #longevity #biohacking

This #MyelomaActionMonth we are recognizing the importance of scientific progress to advance treatment options for #multiplemyeloma. We are continuing to invest in innovative treatment modalities and identifying effective research approaches so that we can work towards progress for patients around the world. Learn more about how we’re committed to helping patients with this disease: https://bit.ly/3T30DJw

Our goal is to redefine treatments for immune-mediated diseases by delivering transformational and accessible therapies, based on our deep understanding of the underlying immune pathways that cause them. In a recent article by The Economist, we discuss how we’re breaking new ground by integrating our scientific and commercial expertise to develop transformational treatments with the potential to help more patients achieve durable, symptom-free remission: https://bit.ly/3UmQJ7B #JNJImmunology